A Faster Finish May Depend On A Better Start – EMA's PRIME Program
This article was originally published in The Pink Sheet Daily
EMA officials spotlight need to improve clinical development plans in the early stages, with agency exec director Rasi saying many trials are "useless." They shy away from predicting timelines or goals for quicker reviews.
Register for our free email digests: